205 related articles for article (PubMed ID: 19238112)
21. Increased serum high mobility group box-1 level in Churg-Strauss syndrome.
Taira T; Matsuyama W; Mitsuyama H; Kawahara KI; Higashimoto I; Maruyama I; Osame M; Arimura K
Clin Exp Immunol; 2007 May; 148(2):241-7. PubMed ID: 17437420
[TBL] [Abstract][Full Text] [Related]
22. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan.
Muta H; Ishii M; Egami K; Furui J; Sugahara Y; Akagi T; Nakamura Y; Yanagawa H; Matsuishi T
J Pediatr; 2004 Apr; 144(4):496-9. PubMed ID: 15069399
[TBL] [Abstract][Full Text] [Related]
23. Novel predictors of intravenous immunoglobulin resistance in Chinese children with Kawasaki disease.
Fu PP; Du ZD; Pan YS
Pediatr Infect Dis J; 2013 Aug; 32(8):e319-23. PubMed ID: 23446442
[TBL] [Abstract][Full Text] [Related]
24. External validation of a risk score to predict intravenous immunoglobulin resistance in patients with kawasaki disease.
Seki M; Kobayashi T; Kobayashi T; Morikawa A; Otani T; Takeuchi K; Ayusawa M; Tsuchiya K; Yasuda K; Suzuki T; Shimoyama S; Ikeda K; Ishii Y; Arakawa H
Pediatr Infect Dis J; 2011 Feb; 30(2):145-7. PubMed ID: 20802375
[TBL] [Abstract][Full Text] [Related]
25. Increased CD11b expression on polymorphonuclear leucocytes and cytokine profiles in patients with Kawasaki disease.
Kobayashi T; Kimura H; Okada Y; Inoue Y; Kobayashi T; Shinohara M; Morikawa A
Clin Exp Immunol; 2007 Apr; 148(1):112-8. PubMed ID: 17286760
[TBL] [Abstract][Full Text] [Related]
26. High mobility group box 1 (HMGB1) protein: possible amplification signal in the pathogenesis of falciparum malaria.
Alleva LM; Yang H; Tracey KJ; Clark IA
Trans R Soc Trop Med Hyg; 2005 Mar; 99(3):171-4. PubMed ID: 15653118
[TBL] [Abstract][Full Text] [Related]
27. Kawasaki disease in a pediatric intensive care unit: a case-control study.
Dominguez SR; Friedman K; Seewald R; Anderson MS; Willis L; Glodé MP
Pediatrics; 2008 Oct; 122(4):e786-90. PubMed ID: 18809597
[TBL] [Abstract][Full Text] [Related]
28. [How does the time of diagnosis affect the course of disease in children with kawasaki syndrome? A retrospective analysis at one center].
Raith W; Gamillscheg A; Heinzl B; Nagel BH; Koestenberger M; Beitzke A
Klin Padiatr; 2009; 221(2):83-8. PubMed ID: 19263328
[TBL] [Abstract][Full Text] [Related]
29. Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma.
Cheng BQ; Jia CQ; Liu CT; Lu XF; Zhong N; Zhang ZL; Fan W; Li YQ
Dig Liver Dis; 2008 Jun; 40(6):446-52. PubMed ID: 18294942
[TBL] [Abstract][Full Text] [Related]
30. Changes in BAFF/APRIL levels in a 2-year-old girl with Kawasaki disease refractory to intravenous immunoglobulin therapy.
Yoshida S; Sakurai Y; Takeda T; Fukuda K
J Investig Allergol Clin Immunol; 2013; 23(1):52-3. PubMed ID: 23653975
[No Abstract] [Full Text] [Related]
31. Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease.
Abe J; Ebata R; Jibiki T; Yasukawa K; Saito H; Terai M
J Allergy Clin Immunol; 2008 Nov; 122(5):1008-1013.e8. PubMed ID: 18930517
[TBL] [Abstract][Full Text] [Related]
32. Expression of myeloid-related protein-8 and -14 in patients with acute Kawasaki disease.
Hirono K; Foell D; Xing Y; Miyagawa-Tomita S; Ye F; Ahlmann M; Vogl T; Futatani T; Rui C; Yu X; Watanabe K; Wanatabe S; Tsubata S; Uese K; Hashimoto I; Ichida F; Nakazawa M; Roth J; Miyawaki T
J Am Coll Cardiol; 2006 Sep; 48(6):1257-64. PubMed ID: 16979015
[TBL] [Abstract][Full Text] [Related]
33. [Clinical analysis of 36 cases of incomplete Kawasaki disease].
Zou CX
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):397-8. PubMed ID: 18554478
[No Abstract] [Full Text] [Related]
34. Cerebral infarction after high-dose intravenous immunoglobulin therapy for Kawasaki disease.
Wada Y; Kamei A; Fujii Y; Ishikawa K; Chida S
J Pediatr; 2006 Mar; 148(3):399-400. PubMed ID: 16615977
[TBL] [Abstract][Full Text] [Related]
35. Resistant Kawasaki disease.
Nachiappan J; May M; Hawker RE; Hong P
J Paediatr Child Health; 2004; 40(9-10):576-8. PubMed ID: 15367156
[No Abstract] [Full Text] [Related]
36. Cardiology patient pages. Kawasaki disease.
Baker AL; Newburger JW
Circulation; 2008 Aug; 118(7):e110-2. PubMed ID: 18695195
[No Abstract] [Full Text] [Related]
37. Serum levels of interleukin-18 are elevated in the subacute phase of kawasaki syndrome.
Nomura Y; Masuda K; Maeno N; Yoshinaga M; Kawano Y
Int Arch Allergy Immunol; 2004 Oct; 135(2):161-5. PubMed ID: 15345916
[TBL] [Abstract][Full Text] [Related]
38. Predictive value of red blood cell distribution width for coronary artery lesions in patients with Kawasaki disease.
Xu H; Fu S; Wang W; Zhang Q; Hu J; Gao L; Zhu W; Gong F
Cardiol Young; 2016 Aug; 26(6):1151-7. PubMed ID: 26435202
[TBL] [Abstract][Full Text] [Related]
39. [Change in T cell-mediated immunity and its relationship with high mobility group box-1 protein levels in extensively burned patients].
Dong N; Jin BQ; Yao YM; Yu Y; Cao YJ; He LX; Chai JK; Sheng ZY
Zhonghua Wai Ke Za Zhi; 2008 May; 46(10):759-62. PubMed ID: 18953932
[TBL] [Abstract][Full Text] [Related]
40. Kawasaki disease in East Mazandaran, Islamic Republic of Iran, 1997-2002.
Saffar MJ; Reshidighader F
East Mediterr Health J; 2005; 11(1-2):28-35. PubMed ID: 16532668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
